Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Stephanie A. Davies"'
Publikováno v:
mAbs, Vol 13, Iss 1 (2021)
Subcutaneous injection of a low volume (100 mg/mL) formulation is an attractive administration strategy for monoclonal antibodies (mAbs) and other biopharmaceutical proteins. Using concentrated solutions may also be beneficial at various stages of bi
Externí odkaz:
https://doaj.org/article/afa5550877874a4fa2303dc1bee8e05b
Autor:
Samuel A. Molina, Stephanie J. Davies, Dalip Sethi, Steve Oh, Nisha Durand, Michael Scott, Lindsay C. Davies, Klaus Wormuth, Dominic Clarke
Publikováno v:
Cytotherapy. 24:1195-1200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8afcd9659dce5555df04461db55c88cb
https://doi.org/10.1016/j.jcyt.2022.07.014
https://doi.org/10.1016/j.jcyt.2022.07.014
Publikováno v:
mAbs
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Subcutaneous injection of a low volume (100 mg/mL) formulation is an attractive administration strategy for monoclonal antibodies (mAbs) and other biopharmaceutical proteins. Using concentrated solutions may also be beneficial at various stages of bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b233384e434f42b688028b3f85fc8a7
https://pubmed.ncbi.nlm.nih.gov/34225583
https://pubmed.ncbi.nlm.nih.gov/34225583
Publikováno v:
Bramham, J E, Podmore, A, Davies, S A & Golovanov, A P 2021, ' Comprehensive Assessment of Protein and Excipient Stability in Biopharmaceutical Formulations Using H-1 NMR Spectroscopy ', ACS Pharmacology & Translational Science, vol. 4, no. 1, pp. 288-295 . https://doi.org/10.1021/acsptsci.0c00188
ACS Pharmacology & Translational Science
ACS Pharmacology & Translational Science
Biopharmaceutical proteins are important drug therapies in the treatment of a range of diseases. Proteins, such as antibodies (Abs) and peptides, are prone to chemical and physical degradation, particularly at the high concentrations currently sought
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef7252eee46f4caaa50286e3985fa858
https://pure.manchester.ac.uk/ws/files/211514568/acsptsci.0c00188.pdf
https://pure.manchester.ac.uk/ws/files/211514568/acsptsci.0c00188.pdf
Autor:
Helen Slater, Stephanie Joy Davies, Richard Parsons, John Louis Quintner, Stephan Alexander Schug
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e38037 (2012)
BACKGROUND: Persistent non-specific low back pain (nsLBP) is poorly understood by the general community, by educators, researchers and health professionals, making effective care problematic. This study evaluated the effectiveness of a policy-into-pr
Externí odkaz:
https://doaj.org/article/fbf2a8347b4f45b5a9c59051bdadd863
Publikováno v:
Journal of Pain Research
Gregory F Parkin-Smith,1,2 Stephanie J Davies,3–5 Lyndon G Amorin-Woods2,61General Practice, Dunsborough WA, Australia; 2School of Health Professions, Murdoch University, Perth, WA, Australia; 3Private Practice Pain Medicine, Painless Clinic, Perth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a039ed7f555646e652c1ab1c500214b
https://doi.org/10.2147/jpr.s136589
https://doi.org/10.2147/jpr.s136589
For a therapeutic monoclonal antibody (mAb) to reach the clinic, the molecule must be produced at an appropriate yield and quality, then formulated to maintain efficacy and stability. The formation of subvisible particles (SVPs) can impact product st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43e090ad47480759fecf89d3b9a10b96
Publikováno v:
BSAVA Congress Proceedings 2018 ISBN: 9781910443583
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::032214ed1894641ce34646022a87785c
https://doi.org/10.22233/9781910443590.30.1
https://doi.org/10.22233/9781910443590.30.1
Autor:
Derek W. Morris, Stephanie J. Davies, James M. Ryan, Pavel V. Baranov, Elaine Kenny, Rosemary O'Connor, Patrick B F O'Connor, Tommie V. McCarthy
Dysregulation of adipose tissue metabolism is associated with multiple metabolic disorders. One such disease, known as Dunnigan-type familial partial lipodystrophy (FPLD2) is characterized by defective fat metabolism and storage. FPLD2 is caused by a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee72b9cc031783c9178aac5dfd58d91
https://europepmc.org/articles/PMC5736245/
https://europepmc.org/articles/PMC5736245/
Autor:
Stephanie Writer-Davies
Publikováno v:
BSAVA Companion. 2017:28-29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59dfc071d217c0974f28ba8dc42bb522
https://doi.org/10.22233/20412495.0617.28
https://doi.org/10.22233/20412495.0617.28